Search

Your search keyword '"de Boer, Marjon A"' showing total 407 results
Start Over Author "de Boer, Marjon A"
407 results on '"de Boer, Marjon A"'

2. Gestational disorders

Author

de Boer, Marjon, Teunissen, Pim W., Ganzevoort, Wessel, de Groot, Christianne J. M., Steegers, Eric A.P., editor, de Groot, Christianne J.M., editor, Hilders, Carina G.J.M., editor, Hoek, Annemieke, editor, Jaddoe, Vincent W.V., editor, Schoenmakers, Sam, editor, and Zweemer, Ronald P., editor

Published
2024
Full Text
View/download PDF

10. Study protocol for two randomised controlled trials evaluating the effects of Cerclage in the reduction of extreme preterm birth and perinatal mortality in twin pregnancies with a short cervix or dilatation: the TWIN Cerclage studies

Author

van Gils, Lissa, primary, de Boer, Marjon A, additional, Bosmans, Judith, additional, Duijnhoven, Ruben, additional, Schoenmakers, Sam, additional, Derks, Jan B, additional, Prins, Jelmer R, additional, Al-Nasiry, Salwan, additional, Lutke Holzik, Margo, additional, Lopriore, Enrico, additional, van Drongelen, Joris, additional, Knol, Marieke H, additional, van Laar, Judith O E H, additional, Jacquemyn, Yves, additional, van Holsbeke, Caroline, additional, Dehaene, Isabelle, additional, Lewi, Liesbeth, additional, van der Merwe, Hannes, additional, Gyselaers, Wilfried, additional, Obermann-Borst, Sylvia A, additional, Holthuis, Mayella, additional, Mol, Ben W, additional, Pajkrt, Eva, additional, and Oudijk, Martijn A, additional

Published
2024
Full Text
View/download PDF

12. Multicentre study and systematic review: Allopurinol exposure during pregnancy.

Author

Crouwel, Femke, Simsek, Melek, de Boer, Marjon A., van Asseldonk, Dirk P., Bhalla, Abha, Weusthuis, Angelique L. M., Gilissen, Lennard P. L., Verburg, Robert J., Mares, Wout G. N., Jharap, Bindia, Kuijvenhoven, Johan P., Oldenburg, Bas, Buiter, Hans J. C., Julsgaard, Mette, and de Boer, Nanne K.

Subjects
PREGNANCY, SMALL for gestational age, MULTIPLE pregnancy, ALLOPURINOL, PREGNANCY outcomes, INFLAMMATORY bowel diseases
Abstract

Summary: Background: Data about the safety of allopurinol in pregnant women are sparsely reported. Aims: To investigate the risk of adverse pregnancy outcome and congenital abnormalities after in utero exposure to allopurinol in inflammatory bowel disease (IBD) pregnancies and in general. Methods: We collected safety data of patients with IBD who were treated with allopurinol during pregnancy between January 2013 and March 2022. Additionally, we performed a systematic review about the teratogenic potential of allopurinol. Results: We collected data from 42 allopurinol‐exposed pregnancies, including one twin pregnancy; in all women, allopurinol was combined with a thiopurine. Six pregnancies (14.3%) resulted in miscarriage and one in stillbirth at 32 weeks. A congenital anomaly was observed in one newborn (coarctation of the aorta discovered postpartum). Three pregnancies, including the twin pregnancy, ended in moderate preterm delivery and one in very preterm delivery. Five neonates (15.2%) were small for gestational age. From our literature search, we identified an additional 102 allopurinol‐exposed pregnancies resulting in 129 live births, including 36 infants from our cohort. Ten infants (7.8%) were born with a congenital anomaly. Two (1.6%) had a comparable pattern of multiple anomalies. The systematic review sub‐analysis including only infants born to mothers with IBD (n = 76) revealed that 2.6% of infants had congenital anomalies after in utero exposure to a low dose of allopurinol. Conclusions: Overall, the teratogenicity of allopurinol remains inconclusive. Children conceived by mothers treated for IBD with allopurinol/thiopurine co‐therapy do not seem to have an increased risk of congenital anomalies. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

14. Cervical pessary versus vaginal progesterone in women with a singleton pregnancy, a short cervix, and no history of spontaneous preterm birth at less than 34 weeks’ gestation: open label, multicentre, randomised, controlled trial

Author

van Dijk, Charlotte E, primary, van Gils, Annabelle L, additional, van Zijl, Maud D, additional, Koullali, Bouchra, additional, van der Weide, Marijke C, additional, van den Akker, Eline S, additional, Hermsen, Brenda J, additional, van Baal, Wilhelmina M, additional, Visser, Henricus, additional, van Drongelen, Joris, additional, Vollebregt, Karlijn C, additional, Muller, Moira, additional, van der Made, Flip W, additional, Gordijn, Sanne J, additional, de Mooij, Yolanda M, additional, Oudijk, Martijn A, additional, de Boer, Marjon A, additional, Mol, Ben WJ, additional, Kazemier, Brenda M, additional, and Pajkrt, Eva, additional

Published
2024
Full Text
View/download PDF

17. The value of a mobile educative Application additional to Standard counselling on aspirin Adherence in Pregnancy: the ASAP study, a randomised controlled trial

Author

bij de Weg, Jeske M. (author), de Boer, Marjon A. (author), Meijer, Cynthia (author), Lugtenburg, Noëlle (author), Melles, M. (author), de Vries, Johanna I.P. (author), de Groot, Christianne J.M. (author), bij de Weg, Jeske M. (author), de Boer, Marjon A. (author), Meijer, Cynthia (author), Lugtenburg, Noëlle (author), Melles, M. (author), de Vries, Johanna I.P. (author), and de Groot, Christianne J.M. (author)

Abstract

Objective: To assess the added value of a novel, mobile educative application to standard counselling on aspirin adherence during pregnancy versus standard counselling alone. Methods: Participants were randomly assigned for additional use of a mobile educative application or standard counselling alone. Main outcome measures were adherence to aspirin measured by two validated questionnaires: Simplified Medication Adherence Questionnaire (SMAQ), Believes and Behaviour Questionnaire (BBQ), and patients reported tablet intake >90%. Results: A total of 174 women with an indication for aspirin during pregnancy were included. The questionnaires were filled in by 126 out of the 174 participants (72.4%). Similar results were found in the app group and the standard counselling groups for both validated questionnaires. Tablet intake >90% was seen in 88.7% and 87.5% (p = 0.834) of the app group and standard counselling group respectively. Subgroup analyses demonstrated a negative effect of BMI and a positive effect of educational level on adherence. Conclusions: Our study revealed no added effect of a novel, mobile educative application to standard counselling on aspirin adherence during pregnancy. Tablet intake was equally high in both groups probably explained by our high educated population. Innovation: Future studies should focus on tailored counselling on medication to pregnant women's needs including medication reminders, addressing concerns, adequate health literacy and side effects, offering rewards to further stimulate aspirin adherence in pregnancy with optimal outcome for mother and their neonate., Applied Ergonomics and Design

Published
2024
Full Text
View/download PDF

18. Gestational disorders

Author

de Boer, Marjon, Teunissen, Pim W., de Groot, Christianne J. M., Steegers, Eric A.P., editor, Fauser, Bart C.J.M., editor, Hilders, Carina G.J.M., editor, Jaddoe, Vincent W.V., editor, Massuger, Leon F.A.G., editor, van der Post, Joris A.M., editor, and Schoenmakers, Sam, editor

Published
2019
Full Text
View/download PDF

22. Methods of induction of labor in women with obesity: A secondary analysis of two multicenter randomized controlled trials

Author

Croll, Dorothée M. R., primary, De Vaan, Marieke D. T., additional, Moes, Shinta L., additional, Bloemenkamp, Kitty W. M., additional, Ten Eikelder, Mieke L. G., additional, De Heus, Roel, additional, Jozwiak, Marta, additional, Kooiman, Judith, additional, Mol, Ben Willem, additional, Verhoeven, Corine J. M., additional, and De Boer, Marjon A., additional

Published
2024
Full Text
View/download PDF

25. 9 Pessary or Cerclage (PC Study) to prevent recurrent preterm delivery – a randomized controlled trial

Author

van Gils, Annabelle L., primary, van Dijk, Charlotte E., additional, Koullali, Bouchra, additional, Lugthart, M.A., additional, Bet, B.B., additional, van Zijl, Maud D., additional, Knol, H.M., additional, Martinez de Tejada, Begoña, additional, Gordijn, Sanne J., additional, Sueters, Marieke, additional, de Boer, Marjon A., additional, van den Akker, Eline S., additional, Hermsen, Brenda J., additional, de Mooij, Yolanda M., additional, de Weerd, Sabina, additional, van Baal, Wilhelmina M., additional, van Hoorn, Marion E., additional, van der Weide, Martine C., additional, Oudijk, Martijn A., additional, Kazemier, Brenda M., additional, Mol, Ben Willem W., additional, and Pajkrt, Eva, additional

Published
2024
Full Text
View/download PDF

32. Evaluation of low-dose aspirin in the prevention of recurrent spontaneous preterm labour (the APRIL study): A multicentre, randomised, double-blinded, placebo-controlled trial

Author

Landman, Anadeijda J. E. M. C., de Boer, Marjon A., Visser, Laura, Nijman, Tobias A. J., Hemels, Marieke A. C., Naaktgeboren, Christiana N., van der Weide, Marijke C., Mol, Ben W., van Laar, Judith O. E. H., Papatsonis, Dimitri N. M., Bekker, Mireille N., van Drongelen, Joris, van Pampus, Mariëlle G., Sueters, Marieke, van der Ham, David P., Sikkema, J. Marko, Zwart, Joost J., Huisjes, Anjoke J. M., van Huizen, Marloes E., Kleiverda, Gunilla, Boon, Janine, Franssen, Maureen T. M., Hermes, Wietske, Visser, Harry, de Groot, Christianne J. M., and Oudijk, Martijn A.

Subjects
Aspirin -- Testing, Premature labor -- Prevention, Biological sciences
Abstract

Background Preterm birth is the leading cause of neonatal morbidity and mortality. The recurrence rate of spontaneous preterm birth is high, and additional preventive measures are required. Our objective was to assess the effectiveness of low-dose aspirin compared to placebo in the prevention of preterm birth in women with a previous spontaneous preterm birth. Methods and findings We performed a parallel multicentre, randomised, double-blinded, placebo-controlled trial (the APRIL study). The study was performed in 8 tertiary and 26 secondary care hospitals in the Netherlands. We included women with a singleton pregnancy and a history of spontaneous preterm birth of a singleton between 22 and 37 weeks. Participants were randomly assigned to aspirin 80 mg daily or placebo initiated between 8 and 16 weeks of gestation and continued until 36 weeks or delivery. Randomisation was computer generated, with allocation concealment by using sequentially numbered medication containers. Participants, their healthcare providers, and researchers were blinded for treatment allocation. The primary outcome was preterm birth grade 1, intraventricular hemorrhage > grade 2, necrotising enterocolitis > stage 1, retinopathy of prematurity, culture proven sepsis, or perinatal death). Analyses were performed by intention to treat. From May 31, 2016 to June 13, 2019, 406 women were randomised to aspirin (n = 204) or placebo (n = 202). A total of 387 women (81.1% of white ethnic origin, mean age 32.5 ± SD 3.8) were included in the final analysis: 194 women were allocated to aspirin and 193 to placebo. Preterm birth Conclusions In this study, we observed that low-dose aspirin did not significantly reduce the preterm birth rate in women with a previous spontaneous preterm birth. However, a modest reduction of preterm birth with aspirin cannot be ruled out. Further research is required to determine a possible beneficial effect of low-dose aspirin for women with a previous spontaneous preterm birth. Trial registration Dutch Trial Register (NL5553, NTR5675) https://www.trialregister.nl/trial/5553., Author(s): Anadeijda J. E. M. C. Landman 1,*, Marjon A. de Boer 1, Laura Visser 1, Tobias A. J. Nijman 2, Marieke A. C. Hemels 3, Christiana N. Naaktgeboren 4, [...]

Published
2022
Full Text
View/download PDF

34. Analysis of Publication Interest on Preterm Birth Over Two Decades

Author

Visser, Laura, de Boer, Marjon A., and de Groot, Christianne J. M.

Subjects
Mortality -- Risk factors, Infants (Premature) -- Health aspects, Health care industry
Abstract

Introduction Preterm birth (PTB) is one of the greatest challenges in obstetric and children's healthcare. PTB remains the most important cause of perinatal morbidity and mortality worldwide. We studied the number of publications concerning PTB over the last two decades using advanced bibliometric visualization methodology. We put the number of publications in perspective of growing awareness of PTB as a major health problem. Methods We analyzed publications over time and performed bibliometric analysis of publications on PTB in the Web of Science from 1997 to 2016. The subjects of publications were visualized using a term map showing the relevant terms occurring in titles and abstracts. Results We identified 47,811 publications. The annual number of publications on PTB increased significantly by 443% in 2016 (n = 5027) compared to 1997 (n = 1135). Obstetrics & Gynecology is the leading research field (with 10.4% on the subject PTB in 2016) followed closely by Pediatrics (7.6% on the subject PTB in 2016), within the field Public, Environmental & Occupational Health minimal increase was observed (only 1% was published on the subject PTB in 2016). The publications on PTB have increased at higher rates than the overall increase of publications. In recent years we found more publications on PTB describing epidemiology and clinical characteristics/outcomes whereas in earlier years publications focused more on translational, basic research. Conclusion A significant increase in research concerning PTB was observed over the last two decades. This increase of publications is in line with the growing global awareness of the need to reduce PTB by clinical research., Author(s): Laura Visser [sup.1] , Marjon A. de Boer [sup.1] , Christianne J. M. de Groot [sup.1] Author Affiliations: (Aff1) 0000 0004 1754 9227, grid.12380.38, Department of Obstetrics and Gynecology, [...]

Published
2019
Full Text
View/download PDF

36. The effect of low-dose aspirin on platelet function during pregnancy compared to placebo: An explorative study

Author

Bij de Weg, Jeske M., Landman, Anadeijda J. E. M. C., de Vries, Johanna I. P., Thijs, Abel, Harmsze, Ankie M., Oudijk, Martijn A., de Boer, Marjon A., Obstetrics and gynaecology, AMS - Rehabilitation & Development, Amsterdam Reproduction & Development (AR&D), VU University medical center, Internal medicine, ACS - Diabetes & metabolism, AGEM - Endocrinology, metabolism and nutrition, AGEM - Inborn errors of metabolism, and Obstetrics and Gynaecology

Subjects
Thromboxane B2, Aspirin, Platelet Function Tests, Double-Blind Method, Reproductive Medicine, Pregnancy, Infant, Newborn, Humans, Premature Birth, Obstetrics and Gynecology, Female
Abstract

OBJECTIVES: To evaluate the effect of aspirin 80 mg compared to placebo on platelet function tests in the second and third trimester of pregnancy. STUDY DESIGN: An explorative study was performed to assess laboratory platelet function in a subpopulation of the APRIL trial: a randomized double-blind trial comparing aspirin 80 mg once daily to placebo for the prevention of recurrent preterm birth. Platelet function was measured between 18 and 22, and between 28 and 32 weeks gestational age with three platelet function tests: VerifyNow®, Chronolog light transmission aggregometry (Chronolog LTA) and serum thromboxane B2 (TxB2). Medication adherence was evaluated by pill counts, self-reported diaries and structured interviews. RESULTS: We included 11 women, six in the aspirin and five in the placebo group. In women receiving aspirin, platelet function was significantly lower compared to women receiving placebo for all three tests: VerifyNow® Aspirin Reaction Units (450.5 vs 648.0, p = 0.017); Chronolog LTA (9.5% vs 94.5%, p = 0.009); serum TxB2 levels (11.9 ng/mL versus 175.9 ng/mL, p = 0.030). For all three tests, platelet function did not differ between the second and third trimester of pregnancy in the aspirin group. In the placebo group, serum TxB2 levels were significantly higher in the third trimester. One non-adherent participant in the aspirin group showed results similar to the placebo group. CONCLUSION: Aspirin 80 mg has a clear inhibitory effect on laboratory platelet function during pregnancy compared to placebo. This effect is similar in the second and third trimester of pregnancy.

Published
2022

38. Spontaneous Haemoperitoneum in Pregnancy: Nationwide Surveillance and Delphi Audit System

Author

Schreurs, Anneke M. F., primary, Overtoom, Evelien M., additional, de Boer, Marjon A., additional, van der Houwen, Lisette E. E., additional, Lier, Marit C. I., additional, van den Akker, Thomas, additional, Cornette, Jerome, additional, Vogelvang, Tatjana E., additional, Beenakkers, Ingrid C. M., additional, Rosman, Ageeth N., additional, Maas, Jacques W. M., additional, Heineman, David J., additional, Finken, Martijn J. J., additional, de Vries, Jan J. J., additional, Burger, Nicole B., additional, Schaap, Timme P., additional, Bloemenkamp, Kitty W. M., additional, and Mijatovic, Velja, additional

Published
2023
Full Text
View/download PDF

44. Spontaneous Haemoperitoneum in Pregnancy:Nationwide Surveillance and Delphi Audit System

Author

Schreurs, Anneke M.F., Overtoom, Evelien M., de Boer, Marjon A., van der Houwen, Lisette E.E., Lier, Marit C.I., van den Akker, Thomas, Cornette, Jerome, Vogelvang, Tatjana E., Beenakkers, Ingrid C.M., Rosman, Ageeth N, Maas, Jacques W.M., Heineman, David J., Finken, Martijn J.J., de Vries, Jan J.J., Burger, Nicole B., Schaap, Timme P., Bloemenkamp, Kitty W.M., Mijatovic, Velja, Schreurs, Anneke M.F., Overtoom, Evelien M., de Boer, Marjon A., van der Houwen, Lisette E.E., Lier, Marit C.I., van den Akker, Thomas, Cornette, Jerome, Vogelvang, Tatjana E., Beenakkers, Ingrid C.M., Rosman, Ageeth N, Maas, Jacques W.M., Heineman, David J., Finken, Martijn J.J., de Vries, Jan J.J., Burger, Nicole B., Schaap, Timme P., Bloemenkamp, Kitty W.M., and Mijatovic, Velja

Abstract

Objective: To evaluate the incidence, diagnostic management strategies and clinical outcomes of women with spontaneous haemoperitoneum in pregnancy (SHiP) and reassess the definition of SHiP. Design: A population-based cohort study using the Netherlands Obstetric Surveillance System (NethOSS). Setting: Nationwide, the Netherlands. Population: All pregnant women between April 2016 and April 2018. Methods: This is a case study of SHiP using the monthly registry reports of NethOSS. Complete anonymised case files were obtained. A newly introduced online Delphi audit system (DAS) was used to evaluate each case, to make recommendations on improving the management of SHiP and to propose a new definition of SHiP. Main outcome measures: Incidence and outcomes, lessons learned about clinical management and the critical appraisal of the current definition of SHiP. Results: In total, 24 cases were reported. After a Delphi procedure, 14 cases were classified as SHiP. The nationwide incidence was 4.9 per 100 000 births. Endometriosis and conceiving after artificial reproductive techniques were identified as risk factors. No maternal and three perinatal deaths occurred. Based on the DAS, adequate imaging of free intra-abdominal fluid, and identifying and treating women with signs of hypovolemic shock could improve the early detection and management of SHiP. A revised definition of SHiP was proposed, excluding the need for surgical or radiological intervention. Conclusions: SHiP is a rare and easily misdiagnosed condition that is associated with high perinatal mortality. To improve care, better awareness among healthcare workers is needed. The DAS is a sufficient tool to audit maternal morbidity and mortality.

Published
2023

45. The influence of various induction methods on adverse outcomes in small for gestational age neonates:A secondary analysis of the PROBAAT 1 and 2 trials

Author

de Vaan, Marieke D.T., Croll, Dorothée M.R., Verhoeven, Corine J.M., de Boer, Marjon A., Jozwiak, Marta, ten Eikelder, Mieke L.G., Mol, Ben Willem, Bloemenkamp, Kitty W.M., de Heus, Roel, de Vaan, Marieke D.T., Croll, Dorothée M.R., Verhoeven, Corine J.M., de Boer, Marjon A., Jozwiak, Marta, ten Eikelder, Mieke L.G., Mol, Ben Willem, Bloemenkamp, Kitty W.M., and de Heus, Roel

Abstract

Objective: To evaluate the safety aspects of different induction methods in pregnancies with small-for-gestational-age neonates. Study design: This was a secondary analysis of two previously reported multicenter, randomized controlled trials conducted in the Netherlands. In the original trials, women were randomized to either a 30 cc Foley catheter, vaginal prostaglandin E2 (PROBAAT-1) or oral misoprostol (PROBAAT-2). A total of 425 patients with a term, singleton pregnancy in cephalic presentation with an indication for labor induction and a small-for-gestational-age neonate were included in this secondary analysis. Our primary outcome was a composed adverse neonatal outcome of Apgar score < 7 after 5 min and/or a pH in the umbilical artery < 7.05 and/or NICU admission. Secondary outcomes were mode of birth, operative birth for fetal distress and pH < 7.10 in the umbilical artery. For these outcome measures, multivariate as well as bivariate analyses were performed. Results: An adverse neonatal outcome occurred in 4.7 % (10/214) induction with a Foley catheter, versus 12.8 % (19/149) after misoprostol (RR 0.36; 95 % CI 0.17–0.76) and 4.7 % (3/64) after Prostaglandin E2 (RR 0.98; 95 %CI 0.28–3.51). For individual components of the composed outcome of adverse events, a difference was found between a Foley catheter and misoprostol for Apgar score < 7 at 5 min (0.5 % versus 3.4; RR 0.14; 95 %CI 0.02–1.16) and NICU admission (1.9 % versus 6.1 %; RR 0.31; 0.10–0.97). No differences were found for mode of birth. Conclusions: For women who gave birth to a small-for-gestational-age neonate, a Foley catheter is probably a safer induction method compared to oral misoprostol.

Published
2023

46. Spontaneous Haemoperitoneum in Pregnancy: Nationwide Surveillance and Delphi Audit System

Author

MS Verloskunde, Medische staf Anesthesiologie, Child Health, Schreurs, Anneke M F, Overtoom, Evelien M, de Boer, Marjon A, van der Houwen, Lisette E E, Lier, Marit C I, van den Akker, Thomas, Cornette, Jerome, Vogelvang, Tatjana E, Beenakkers, Ingrid C M, Rosman, Ageeth N, Maas, Jacques W M, Heineman, David J, Finken, Martijn J J, de Vries, Jan J J, Burger, Nicole B, Schaap, Timme P, Bloemenkamp, Kitty W M, Mijatovic, Velja, MS Verloskunde, Medische staf Anesthesiologie, Child Health, Schreurs, Anneke M F, Overtoom, Evelien M, de Boer, Marjon A, van der Houwen, Lisette E E, Lier, Marit C I, van den Akker, Thomas, Cornette, Jerome, Vogelvang, Tatjana E, Beenakkers, Ingrid C M, Rosman, Ageeth N, Maas, Jacques W M, Heineman, David J, Finken, Martijn J J, de Vries, Jan J J, Burger, Nicole B, Schaap, Timme P, Bloemenkamp, Kitty W M, and Mijatovic, Velja

Published
2023

47. The influence of various induction methods on adverse outcomes in small for gestational age neonates: A secondary analysis of the PROBAAT 1 and 2 trials

Author

MS Verloskunde, Child Health, de Vaan, Marieke D.T., Croll, Dorothée M.R., Verhoeven, Corine J.M., de Boer, Marjon A., Jozwiak, Marta, ten Eikelder, Mieke L.G., Mol, Ben Willem, Bloemenkamp, Kitty W.M., de Heus, Roel, MS Verloskunde, Child Health, de Vaan, Marieke D.T., Croll, Dorothée M.R., Verhoeven, Corine J.M., de Boer, Marjon A., Jozwiak, Marta, ten Eikelder, Mieke L.G., Mol, Ben Willem, Bloemenkamp, Kitty W.M., and de Heus, Roel

Published
2023

50. Cervical pessary versus vaginal progesterone in singletons with a short cervix: a randomized controlled trial

Author

van Dijk, Charlotte E., primary, van Gils, Annabelle L., additional, van Zijl, Maud D., additional, Koullali, Bouchra, additional, van der Weide, Martine C., additional, van den Akker, Eline S., additional, Hermsen, Brenda J., additional, van Baal, Wilhelmina M., additional, Visser, Henricus, additional, van Drongelen, Joris, additional, Vollebregt, Karlijn C., additional, Muller, Moira, additional, van der Made, Flip W., additional, Gordijn, Sanne J., additional, Hooker, Angelo, additional, Research Group, Quadruple P., additional, Oudijk, Martijn A., additional, de Boer, Marjon A., additional, Mol, Ben Willem W., additional, Kazemier, Brenda M., additional, and Pajkrt, Eva, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results